't Hoen EFM - Search Results

1

Data exclusivity exceptions and compulsory licensing to promote generic medicines in the European Union: A proposal for greater coherence in European pharmaceutical legislation.

't Hoen EFM, Boulet P, Baker BK. 't Hoen EFM, et al. J Pharm Policy Pract. 2017 Jun 28;10:19. doi: 10.1186/s40545-017-0107-9. eCollection 2017. J Pharm Policy Pract. 2017. PMID: 28670455 Free PMC article. Review.

2

Patent challenges in the procurement and supply of generic new essential medicines and lessons from HIV in the southern African development community (SADC) region.

't Hoen EFM, Kujinga T, Boulet P. 't Hoen EFM, et al. J Pharm Policy Pract. 2018 Dec 4;11:31. doi: 10.1186/s40545-018-0157-7. eCollection 2018. J Pharm Policy Pract. 2018. PMID: 30524732 Free PMC article. Review.

3

Overriding drug and medical technology patents for pandemic recovery: a legitimate move for high-income countries, too.

Perehudoff K, 't Hoen E, Boulet P. Perehudoff K, et al. BMJ Glob Health. 2021 Apr;6(4):e005518. doi: 10.1136/bmjgh-2021-005518. BMJ Glob Health. 2021. PMID: 33827793 Free PMC article. No abstract available.

4

A pandemic treaty for equitable global access to medical countermeasures: seven recommendations for sharing intellectual property, know-how and technology.

Perehudoff K, 't Hoen E, Mara K, Balasubramaniam T, Abbott F, Baker B, Boulet P, Kamal-Yanni M, Martin M, Munoz Tellez V, Natsis Y, Ortún-Rubio V, Rathod S, Torrent M, Vawda Y, Villarroel L, Love J. Perehudoff K, et al. BMJ Glob Health. 2022 Jul;7(7):e009709. doi: 10.1136/bmjgh-2022-009709. BMJ Glob Health. 2022. PMID: 35840169 Free PMC article. No abstract available.

5

Does the political will exist to bring quality-assured and affordable drugs to low- and middle-income countries?

Beck EJ, Mandalia S, DongmoNguimfack B, Pinheiro E, 't Hoen E, Boulet P, Stover J, Gupta A, Juneja S, Habiyambere V, Ghys P, Nunez C. Beck EJ, et al. Glob Health Action. 2019;12(1):1586317. doi: 10.1080/16549716.2019.1586317. Glob Health Action. 2019. PMID: 30983547 Free PMC article.

6

A quiet revolution in global public health: The World Health Organization's Prequalification of Medicines Programme.

't Hoen EF, Hogerzeil HV, Quick JD, Sillo HB. 't Hoen EF, et al. J Public Health Policy. 2014 May;35(2):137-61. doi: 10.1057/jphp.2013.53. Epub 2014 Jan 16. J Public Health Policy. 2014. PMID: 24430804

7

Viewpoint: Counterfeit medicines and substandard medicines: Different problems requiring different solutions.

't Hoen E, Pascual F. 't Hoen E, et al. J Public Health Policy. 2015 Nov;36(4):384-9. doi: 10.1057/jphp.2015.22. Epub 2015 Jul 16. J Public Health Policy. 2015. PMID: 26178809

8

Essential medicines are still essential.

Gray AL, Wirtz VJ, 't Hoen EF, Reich MR, Hogerzeil HV. Gray AL, et al. Lancet. 2015 Oct 24;386(10004):1601-3. doi: 10.1016/S0140-6736(15)00514-0. Lancet. 2015. PMID: 26595616 No abstract available.

9

Compulsory Licenses For Medicines.

't Hoen E, Bermudez J. 't Hoen E, et al. Health Aff (Millwood). 2015 Jun;34(6):1068. doi: 10.1377/hlthaff.2015.0452. Health Aff (Millwood). 2015. PMID: 26056219 No abstract available.

10

Medicine procurement and the use of flexibilities in the Agreement on Trade-Related Aspects of Intellectual Property Rights, 2001-2016.

't Hoen EF, Veraldi J, Toebes B, Hogerzeil HV. 't Hoen EF, et al. Bull World Health Organ. 2018 Mar 1;96(3):185-193. doi: 10.2471/BLT.17.199364. Epub 2018 Feb 5. Bull World Health Organ. 2018. PMID: 29531417 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

42 results

Search Page